| Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study YY Liu, Y Wang, TR Walsh, LX Yi, R Zhang, J Spencer, Y Doi, G Tian, ... The Lancet infectious diseases 16 (2), 161-168, 2016 | 5529 | 2016 |
| The global epidemiology of carbapenemase-producing Enterobacteriaceae D van Duin, Y Doi Virulence 8 (4), 460-469, 2017 | 824 | 2017 |
| 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides Y Doi, Y Arakawa Clinical Infectious Diseases 45 (1), 88-94, 2007 | 722 | 2007 |
| Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens ZA Qureshi, DL Paterson, BA Potoski, MC Kilayko, G Sandovsky, ... Antimicrobial agents and chemotherapy 56 (4), 2108-2113, 2012 | 641 | 2012 |
| Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae D Van Duin, JJ Lok, M Earley, E Cober, SS Richter, F Perez, RA Salata, ... Clinical Infectious Diseases 66 (2), 163-171, 2018 | 574 | 2018 |
| PCR typing of genetic determinants for metallo-â-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron N Shibata, Y Doi, K Yamane, T Yagi, H Kurokawa, K Shibayama, H Kato, ... Journal of Clinical Microbiology 41 (12), 5407-5413, 2003 | 534 | 2003 |
| Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a … M Bassetti, R Echols, Y Matsunaga, M Ariyasu, Y Doi, R Ferrer, TP Lodise, ... The Lancet infectious diseases 21 (2), 226-240, 2021 | 501 | 2021 |
| Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective … B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... The Lancet Infectious Diseases 17 (7), 726-734, 2017 | 479 | 2017 |
| Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae … RK Shields, L Chen, S Cheng, KD Chavda, EG Press, A Snyder, ... Antimicrobial agents and chemotherapy 61 (3), 10.1128/aac. 02097-16, 2017 | 470 | 2017 |
| Treatment options for carbapenem-resistant gram-negative bacterial infections Y Doi Clinical Infectious Diseases 69 (Supplement_7), S565-S575, 2019 | 460 | 2019 |
| Ceftazidime-avibactam is superior to other treatment regimens against carbapenem-resistant Klebsiella pneumoniae bacteremia RK Shields, MH Nguyen, L Chen, EG Press, BA Potoski, RV Marini, Y Doi, ... Antimicrobial agents and chemotherapy 61 (8), 10.1128/aac. 00883-17, 2017 | 451 | 2017 |
| Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance ZA Qureshi, LE Hittle, JA O'Hara, JI Rivera, A Syed, RK Shields, ... Clinical infectious diseases 60 (9), 1295-1303, 2015 | 447 | 2015 |
| Clinical outcomes, drug toxicity, and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections RK Shields, BA Potoski, G Haidar, B Hao, Y Doi, L Chen, EG Press, ... Clinical Infectious Diseases 63 (12), 1615-1618, 2016 | 429 | 2016 |
| Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019) MAEG El-Sayed Ahmed, LL Zhong, C Shen, Y Yang, Y Doi, GB Tian Emerging microbes & infections 9 (1), 868-885, 2020 | 427 | 2020 |
| Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa K Yokoyama, Y Doi, K Yamane, H Kurokawa, N Shibata, K Shibayama, ... The lancet 362 (9399), 1888-1893, 2003 | 420 | 2003 |
| Procalcitonin-guided use of antibiotics for lower respiratory tract infection DT Huang, DM Yealy, MR Filbin, AM Brown, CCH Chang, Y Doi, ... New England Journal of Medicine 379 (3), 236-249, 2018 | 407 | 2018 |
| Community-Associated Extended-Spectrum â-Lactamase–Producing Escherichia coli Infection in the United States Y Doi, YS Park, JI Rivera, JM Adams-Haduch, A Hingwe, EM Sordillo, ... Clinical Infectious Diseases 56 (5), 641-648, 2013 | 406 | 2013 |
| Aminoglycoside resistance: the emergence of acquired 16S ribosomal RNA methyltransferases Y Doi, J Wachino, Y Arakawa Infectious Disease Clinics 30 (2), 523-537, 2016 | 392 | 2016 |
| Natural history of asymptomatic SARS-CoV-2 infection A Sakurai, T Sasaki, S Kato, M Hayashi, S Tsuzuki, T Ishihara, M Iwata, ... New England Journal of Medicine 383 (9), 885-886, 2020 | 358 | 2020 |
| Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study Y Wang, GB Tian, R Zhang, Y Shen, JM Tyrrell, X Huang, H Zhou, L Lei, ... The Lancet Infectious Diseases 17 (4), 390-399, 2017 | 346 | 2017 |
